Universite de Montreal;The University of Adelaide;Chu Sainte-Justine;The Governors of the University of Alberta
发明人:
Chemtob, Sylvain,Quiniou, Christiane,Robertson, Sarah Anne,Nadeau-Vallee, Mathieu,Lubell, William D.,Olson, David,Chin, Peck Yin,Girard, Sylvie,Duc, Doan-Ngoc
申请号：
AU2016396182
公开号：
AU2016396182A1
申请日:
2016.03.09
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
A method for preventing or reducing the risk of perinatal or neonatal morbidity and mortality caused by antenatal inflammation in humans is described. This method is based on the administration of a compound of formula I or a pharmaceutically acceptable salt thereof to an expectant human mother suffering from antenatal fetal inflammation. The method prevents or reduces the risk of organ damages, including brain, lung and intestinal damages, and sequelae therefrom, in the neonates, as well as the risk of neonatal death.
